| Synonyms: | |
| Status: | Approved (1953) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | A01AB13 |
| UNII: | F8VB5M810T |
| InChI Key | OFVLGDICTFRJMM-WESIUVDSSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H24N2O8 |
| Molecular Weight | 444.44 |
| AlogP | -0.21 |
| Hydrogen Bond Acceptor | 9.0 |
| Hydrogen Bond Donor | 6.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 181.62 |
| Molecular species | ZWITTERION |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 32.0 |
| Property Name | Value | Unit | Method |
|---|---|---|---|
| log P (octanol-water) | -1.30E+00 | - | EXP |
| pKa Dissociation Constant | 3.3 | - | EXP |
| Henry's Law Constant | 4.66E-24 | atm-m3/mole | EST |
| Atmospheric OH Rate Constant | 2.56E-10 | cm3/molecule-sec | EST |
| Melting Point | 172.5 dec | deg C | EXP |
| Water Solubility | 231 | mg/L | EXP |
| Vapor Pressure | 3.09E-23 | mm Hg | EST |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Metallo protease
Metallo protease MAM clan
Metallo protease M10A subfamily
|
- | - | - | - | 100 | |
|
Enzyme
Transferase
|
- | - | - | - | 10 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Nucleotide-like receptor (family A GPCR)
Purine receptor
|
- | - | - | - | 2 | |
|
Other cytosolic protein
|
- | 4580 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 22 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 13200 | - | - | 10 | |
|
Unclassified protein
|
- | 4580 | - | - | 40 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Conjunctivitis, Inclusion | 3 | D003235 | ClinicalTrials |
| Periodontitis | 3 | D010518 | ClinicalTrials |
| Helicobacter Infections | 3 | D016481 | ClinicalTrials |
| Vaginosis, Bacterial | 3 | D016585 | ClinicalTrials |
| Candidiasis, Vulvovaginal | 3 | D002181 | ClinicalTrials |
| Burns | 2 | D002056 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 2 | D008228 | ClinicalTrials |
| Multiple Sclerosis, Chronic Progressive | 1 | D020528 | ClinicalTrials |
| Multiple Sclerosis, Relapsing-Remitting | 1 | D020529 | ClinicalTrials |
| Osteomyelitis | 0 | D010019 | ClinicalTrials |
| Chalazion | 0 | D017043 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 60-54-8 |
| ChEBI | 77932 |
| ChEMBL | CHEMBL1440 |
| DrugBank | DB00759 |
| DrugCentral | 2611 |
| EPA CompTox | DTXSID7023645 |
| FDA SRS | F8VB5M810T |
| Human Metabolome Database | HMDB0014897 |
| Guide to Pharmacology | 10927 |
| KEGG | C06570 |
| PDB | TAC |
| SureChEMBL | SCHEMBL3098 |
| ZINC | ZINC000084441937 |